Do Treatments for Smoking Cessation Affect Alcohol Drinking?
| Status: | Completed | 
|---|---|
| Conditions: | Smoking Cessation, Psychiatric | 
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases | 
| Healthy: | No | 
| Age Range: | 21 - Any | 
| Updated: | 2/9/2018 | 
| Start Date: | April 2007 | 
| End Date: | November 2016 | 
The purpose of this study is to examine the effect of smoking cessation medications on
alcohol drinking. Effect of 2mg/day, 1mg/day, placebo varenicline was evaluated.
Following 7 days of medication pre-treatment to achieve steady state levels, participants
complete a laboratory session assessing alcohol self-administration behavior.
Study enrolls heavy drinking smokers (not tested under nicotine deprivation), non-daily
smokers, and nonsmokers. Volunteers are administered either varenicline (Chantix) or placebo.
			alcohol drinking. Effect of 2mg/day, 1mg/day, placebo varenicline was evaluated.
Following 7 days of medication pre-treatment to achieve steady state levels, participants
complete a laboratory session assessing alcohol self-administration behavior.
Study enrolls heavy drinking smokers (not tested under nicotine deprivation), non-daily
smokers, and nonsmokers. Volunteers are administered either varenicline (Chantix) or placebo.
Inclusion Criteria:
- 21 years old or older
- Able to read and write in English
- Smokers, non-daily smokers, and non-smokers
- Heavy Drinkers and/or meet criteria for alcohol use disorders
Exclusion Criteria:
- Any significant current medical or psychiatric conditions that would contraindicate
the consumption of alcohol
- Significant hepatocellular injury
- Positive test result at intake appointments on urine drug screens conducted for
opiates, cocaine, or benzodiazepines
- Women who are pregnant or nursing
- Suicidal, homicidal, or evidence of severe mental illness
- Prescription of any psychotropic drug in the 30 days prior to study enrollment
- Blood donation within the past 8 weeks
- Individuals who are seeking treatment for drinking or smoking or who have attempted to
quit drinking or smoking within the past 3 months
- Specific exclusions for administration of bupropion not specified above including:
having taken monoamine inhibitors in the past six weeks; history of anorexia or
bulimia; previous hypersensitivity to bupropion; history of alcohol or drug dependence
in the past year; history of seizure disorder of any etiology
- Known allergy to varenicline or taking H2blockers
- Participation within the past 8 weeks in other studies that involve additive blood
sampling and/or interventional measures that would be considered excessive in
combination with the current study
- Subjects likely to exhibit clinically significant alcohol withdrawal during the study
We found this trial at
    1
    site
	
								New Haven, Connecticut 06519			
	
			
					Click here to add this to my saved trials